Biocompatible PLGA-Mesoporous Silicon Microspheres for the Controlled Release of BMP-2 for Bone Augmentation

Bone morphogenetic protein-2 (BMP-2) has been demonstrated to be one of the most vital osteogenic factors for bone augmentation. However, its uncontrolled administration has been associated with catastrophic side effects, which compromised its clinical use. To overcome these limitations, we aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Minardi, Silvia, Fernandez-Moure, Joseph S., Fan, Dongmei, Murphy, Matthew B., Yazdi, Iman K., Liu, Xuewu, Weiner, Bradley K., Tasciotti, Ennio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076394/
https://www.ncbi.nlm.nih.gov/pubmed/32024134
http://dx.doi.org/10.3390/pharmaceutics12020118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076394/
https://www.ncbi.nlm.nih.gov/pubmed/32024134
http://dx.doi.org/10.3390/pharmaceutics12020118

Ejemplares similares